|
EFFIPRO
|
50 mg/pipetē
|
V/DCP/09/0007
|
Virbac S.A., Francija
|
QP53AX15
|
cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/09/0007-01 |
50 mg/pipetē |
1 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-02 |
50 mg/pipetē |
2 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-03 |
50 mg/pipetē |
3 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-04 |
50 mg/pipetē |
4 |
Plastmasas pipete, 0,5 ml |
[JPG]
[JPG]
|
| V/DCP/09/0007-05 |
50 mg/pipetē |
6 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-06 |
50 mg/pipetē |
8 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-07 |
50 mg/pipetē |
12 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-08 |
50 mg/pipetē |
24 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-09 |
50 mg/pipetē |
30 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-10 |
50 mg/pipetē |
60 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-11 |
50 mg/pipetē |
90 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-12 |
50 mg/pipetē |
150 |
Plastmasas pipete, 0,5 ml |
-
|
| V/DCP/09/0007-13 |
50 mg/pipetē |
1 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-14 |
50 mg/pipetē |
2 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-15 |
50 mg/pipetē |
3 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-16 |
50 mg/pipetē |
4 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-17 |
50 mg/pipetē |
6 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-18 |
50 mg/pipetē |
8 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-19 |
50 mg/pipetē |
12 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-20 |
50 mg/pipetē |
24 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-21 |
50 mg/pipetē |
30 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-22 |
50 mg/pipetē |
60 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-23 |
50 mg/pipetē |
90 |
Termoformēta pipete, 0,5 ml |
-
|
| V/DCP/09/0007-24 |
50 mg/pipetē |
150 |
Termoformēta pipete, 0,5 ml |
-
|
|
|
Tsefalen
|
500 mg
|
V/DCP/12/0057
|
NEXTMUNE ITALY S.R.L., Itālija
|
QJ01DB01
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/12/0057-01 |
500 mg |
1 |
PVH/Al blisteris, 12 tablete |
-
|
| V/DCP/12/0057-02 |
500 mg |
9 |
PVH/Al blisteris, 12 tablete |
-
|
| V/DCP/12/0057-03 |
500 mg |
3 |
PVH/Al blisteris, 12 tablete |
-
|
|
|
Trilotab vet
|
10 mg
|
V/DCP/23/0039
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0039-01 |
|
3 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
| V/DCP/23/0039-02 |
|
10 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
|
|
Trilotab vet
|
30 mg
|
V/DCP/23/0040
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0040-01 |
|
3 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
| V/DCP/23/0040-02 |
|
10 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
|
|
Trilotab vet
|
60 mg
|
V/DCP/23/0041
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0041-01 |
|
3 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
| V/DCP/23/0041-02 |
|
10 |
AL/PVC-AL-PA blisteris, 10 tablete |
-
|
|
|
Alphafluben
|
50 mg/g
|
V/DCP/20/0012
|
Alphavet Zrt., Ungārija
|
QP52AC12
|
pigs; chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
premix for medicated feeding stuff
|
| International name (active substance): |
Flubendazole
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Alphavet Zrt., Ungārija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 14012025LI (14-Jan-2025)
|
| Labelling text: |
[DOCX] 14012025M (14-Jan-2025)
|
| Summary of product characteristics: |
[DOCX] 14012025ZA (14-Jan-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0012-01 |
50 mg/g |
1 |
Trīs slāņu papīra maiss ar polietilēna iekšējo slāni , 12 kg |
-
|
|
|
Versican Plus Bb Oral
|
-
|
V/MRP/19/0060
|
Zoetis Belgium SA., Beļģija
|
QI07AE01
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/19/0060-01 |
|
5 |
Stikla flakons, 1 deva |
-
|
| V/MRP/19/0060-02 |
|
10 |
Stikla flakons, 1 deva |
-
|
| V/MRP/19/0060-03 |
|
25 |
Stikla flakons, 1 deva |
-
|
|
|
Rispoval RS+Pi3 IntraNasal
|
-
|
V/MRP/06/1678
|
Zoetis Belgium S.A., Beļģija
|
QI02AD07
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
nasal spray, lyophilisate and solvent for suspension
|
| International name (active substance): |
Bovine Parainfluenza 3 virus (Pi3V), modified live strain RLB 103, Bovine Respiratory Syncytial Virus (BRSV), modified live strain 375
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
07-Oct-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (24-Apr-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/06/1678-01 |
|
1 |
Stikla flakons, 5 deva |
-
|
| V/MRP/06/1678-02 |
|
1 |
Stikla flakons, 25 deva |
-
|
| V/MRP/06/1678-03 |
|
5 |
Stikla flakons, 1 deva |
-
|
|
|
Drontal Puppy
|
-
|
V/MRP/08/1590
|
Vetoquinol S.A., Francija
|
QP52AC55
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/08/1590-01 |
|
1 |
Flakons, 50 ml |
-
|
| V/MRP/08/1590-02 |
|
1 |
Flakons, 100 ml |
-
|
|
|
Ketodolor
|
100 mg/ml
|
V/DCP/13/0020
|
Le Vet Beheer B.V., Nīderlande
|
QM01AE03
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Ketoprofen
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Produlab Pharma b.v., Nīderlande
|
| Date of authorisation/renewal: |
06-Dec-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] 27112018LI (27-Nov-2018)
|
| Labelling text: |
[PDF] 27112018M (27-Nov-2018)
|
| Summary of product characteristics: |
[PDF] 27112018ZA (27-Nov-2018)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/13/0020-01 |
100 mg/ml |
1 |
Stikla pudelīte (dzintarkrāsas), 50 ml |
-
|
| V/DCP/13/0020-02 |
100 mg/ml |
1 |
Stikla pudelīte (dzintarkrāsas), 100 ml |
-
|
|
|
Pigfen
|
40 mg/g
|
V/DCP/15/0033
|
Huvepharma NV, Beļģija
|
QP52AC13
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0033-01 |
40 mg/g |
1 |
Maiss, 250 g |
-
|
| V/DCP/15/0033-02 |
40 mg/g |
1 |
Maiss, 500 g |
-
|
| V/DCP/15/0033-03 |
40 mg/g |
1 |
Maiss, 1 kg |
-
|
|
|
Pigfen
|
200 mg/ml
|
V/DCP/18/0011
|
Huvepharma NV, Beļģija
|
QP52AC13
|
pigs
|
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0011-01 |
|
1 |
ABPE pudele, 125 ml |
-
|
| V/DCP/18/0011-02 |
|
1 |
ABPE pudele (cilindriska), 1 l |
-
|
| V/DCP/18/0011-03 |
|
1 |
ABPE pudele (taisnstūrveida), 1 l |
-
|
| V/DCP/18/0011-04 |
|
1 |
Kanna, 2,5 l |
-
|
| V/DCP/18/0011-05 |
|
1 |
Kanna, 5 l |
-
|
|
|
Milprazon CHEWABLE 2,5 mg/25 mg
|
-
|
V/DCP/21/0052
|
KRKA, d.d., Novo mesto, Slovēnija
|
QP54AB51
|
small dogs; puppies weighing at least 0.5 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0052-01 |
2,5/25 mg |
1 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/21/0052-02 |
2,5/25 mg |
1 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/21/0052-03 |
2,5/25 mg |
12 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
|
|
Milprazon CHEWABLE 12,5 mg/125 mg
|
-
|
V/DCP/21/0053
|
KRKA, d.d., Novo mesto, Slovēnija
|
QP54AB51
|
dogs weighing at least 5 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0053-01 |
12,5/125 mg |
1 |
Al/OPA/Al/PVH blisteris, 2 tablete |
-
|
| V/DCP/21/0053-02 |
12,5/125 mg |
1 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
| V/DCP/21/0053-03 |
12,5/125 mg |
12 |
Al/OPA/Al/PVH blisteris, 4 tablete |
-
|
|
|
Clavaseptin 62.5 mg
|
-
|
V/DCP/13/0006
|
Vetoquinol S.A., Francija
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/13/0006-01 |
|
1 |
Al/Al blisteris, 10 tablete |
-
|
| V/DCP/13/0006-02 |
|
10 |
Al/Al blisteris, 10 tablete |
-
|
| V/DCP/13/0006-03 |
|
25 |
Al/Al blisteris, 10 tablete |
-
|
| V/DCP/13/0006-04 |
|
50 |
Al/Al blisteris, 10 tablete |
-
|
|
|
EFFIPRO
|
67 mg/pipetē
|
V/DCP/09/0008
|
Virbac S.A., Francija
|
QP53AX15
|
small dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/09/0008-01 |
67 mg/pipetē |
1 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-02 |
67 mg/pipetē |
2 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-03 |
67 mg/pipetē |
3 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-04 |
67 mg/pipetē |
4 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-05 |
67 mg/pipetē |
6 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-06 |
67 mg/pipetē |
8 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-07 |
67 mg/pipetē |
12 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-08 |
67 mg/pipetē |
24 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-09 |
67 mg/pipetē |
30 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-10 |
67 mg/pipetē |
60 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-11 |
67 mg/pipetē |
90 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-12 |
67 mg/pipetē |
150 |
Polipropilēna pipete, 0,67 ml |
-
|
| V/DCP/09/0008-49 |
67 mg/pipetē |
1 |
Termoformēta pipete, 0,67 ml |
-
|
| V/DCP/09/0008-50 |
67 mg/pipetē |
2 |
Termoformēta pipete, 0,67 ml |
-
|
| V/DCP/09/0008-51 |
67 mg/pipetē |
3 |
Termoformēta pipete, 0,67 ml |
-
|
| V/DCP/09/0008-52 |
67 mg/pipetē |
4 |
Termoformēta pipete, 0,67 ml |
-
|
| V/DCP/09/0008-53 |
67 mg/pipetē |
6 |
Termoformēta pipete, 0,67 ml |
-
|
| V/DCP/09/0008-54 |
67 mg/pipetē |
8 |
Termoformēta pipete, 0,67 ml |
-
|
| V/DCP/09/0008-55 |
67 mg/pipetē |
12 |
Termoformēta pipete, 0,67 ml |
-
|
| V/DCP/09/0008-56 |
67 mg/pipetē |
24 |
Termoformēta pipete, 0,67 ml |
-
|
|
|
EFFIPRO
|
134 mg/pipetē
|
V/DCP/22/0031
|
Virbac S.A., Francija
|
QP53AX15
|
medium dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0031-01 |
134 mg/pipetē |
1 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-02 |
134 mg/pipetē |
2 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-03 |
134 mg/pipetē |
3 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-04 |
134 mg/pipetē |
4 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-05 |
134 mg/pipetē |
6 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-06 |
134 mg/pipetē |
8 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-07 |
134 mg/pipetē |
12 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-08 |
134 mg/pipetē |
24 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-09 |
134 mg/pipetē |
30 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-10 |
134 mg/pipetē |
60 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-11 |
134 mg/pipetē |
90 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-12 |
134 mg/pipetē |
150 |
Plastmasas pipete, 1,34 ml |
-
|
| V/DCP/22/0031-13 |
134 mg/pipetē |
1 |
Termoformēta pipete, 1,34 ml |
-
|
| V/DCP/22/0031-14 |
134 mg/pipetē |
2 |
Termoformēta pipete, 1,34 ml |
-
|
| V/DCP/22/0031-15 |
134 mg/pipetē |
3 |
Termoformēta pipete, 1,34 ml |
-
|
| V/DCP/22/0031-16 |
134 mg/pipetē |
4 |
Termoformēta pipete, 1,34 ml |
-
|
| V/DCP/22/0031-17 |
134 mg/pipetē |
6 |
Termoformēta pipete, 1,34 ml |
-
|
| V/DCP/22/0031-18 |
134 mg/pipetē |
8 |
Termoformēta pipete, 1,34 ml |
-
|
| V/DCP/22/0031-19 |
134 mg/pipetē |
12 |
Termoformēta pipete, 1,34 ml |
-
|
| V/DCP/22/0031-20 |
134 mg/pipetē |
24 |
Termoformēta pipete, 1,34 ml |
-
|
|
|
Biocan Novel Respi
|
-
|
V/DCP/20/0020
|
Bioveta, a.s., Čehija
|
QI07AF01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for nasal drops
|
| International name (active substance): |
Live attenuated Bordetella bronchiseptica, strain MSLB 3096, Live attenuated Canine parainfluenza Type 2 virus, strain CPiV2-Bio15
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
|
| Labelling text: |
[PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0020-01 |
|
5 |
Stikla flakons, 1 deva |
-
|
| V/DCP/20/0020-02 |
|
10 |
Stikla flakons, 1 deva |
-
|
|
|
Curacef Duo
|
-
|
V/DCP/14/0045
|
VIRBAC, Francija
|
QJ01DD99
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0045-01 |
|
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/14/0045-02 |
|
1 |
Stikla flakons, 100 ml |
-
|
| V/DCP/14/0045-03 |
|
1 |
Stikla flakons, 250 ml |
-
|
| V/DCP/14/0045-04 |
|
1 |
Polipropilēna flakons, 50 ml |
-
|
| V/DCP/14/0045-05 |
|
1 |
Polipropilēna flakons, 100 ml |
-
|
| V/DCP/14/0045-06 |
|
1 |
Polipropilēna flakons, 250 ml |
-
|
|
|
Sedanol
|
40 mg/ml
|
V/DCP/20/0013
|
VetViva Richter GmbH , Austrija
|
QN05AD90
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0013-01 |
40 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/DCP/20/0013-02 |
40 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|